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The gut microbiome facilitates a consistent transfer of information between the gut and the 
brain and microRNAs may now represent a key signalling molecule that facilitates this 
relationship. This review will firstly examine how these small non-coding RNAs influence the 
gut microbiome, and secondly how the microbiome, when disturbed, may influence miRNA 
expression in the brain. In addition, we will examine the consequence that microbiome-related 
changes in miRNA expression have on neurodevelopment, behaviour and cognition. We will 
also discuss novel data that suggests miRNAs contained in our diet may influence our immune 
system in a positive manner, offering a further potential pathway for treatment of disorders of 
the gut-brain axis that are influenced by the microbiome.  
 
Introduction 
Recent research continues to expand on the scope of influence of the gut microbiome on the 
gut-brain axis and to identify an expanding range of microbially-regulated molecular targets in 
both the gut and the brain. In particular the transcriptional landscape in brain regions of 
functional importance to stress-related psychiatric disorders is markedly impacted by gut 
microbiome manipulations. Added to this portfolio is the ability to exert an impact on the 
expression of microRNAs in discrete brain regions. Moreover, there is a reciprocal impact of 
host-derived miRNAs locally in the gut. In this review, we provide a brief overview of the 
fundamentals of miRNAs and then discuss the most important recent advances in this area 
and their implications for host-microbe interactions.  
What do MicroRNAs do?  
MicroRNAs (miRNAs) are small, non-coding, single-stranded RNAs that post-transcriptionally 
regulate the expression of cellular mRNAs that contain miRNA binding sites. Their expression 
is widespread [1], and they have a broad influence on cellular development and function [2]. 
Since the discovery of the first miRNA, lin-4, in C. elegans in 1993 [3], an additional layer of 
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complexity has been added to the regulation of gene expression in many healthy and 
pathological cell processes. The primary role of miRNAs appears to be post-transcriptional 
regulation of gene expression and this is achieved through binding to target mRNAs [2]. 
MiRNAs are regulators of various cellular actions including cell growth, differentiation and 
death and as a result have shown promising therapeutic potential in treatment of diseases 
such as cancer and viral infection.  
MicroRNA Structure and Target Recognition  
In humans, miRNAs can exist in numerous genomic contexts, recognised miRNAs are 
encoded by introns from coding and non-coding regions, and  miRNAs can also be encoded 
by exonic regions [4]. Many miRNAs located within the same genomic region can form 
functional clusters that can be transcribed together [5]. miRNAs are directed to their mRNA 
targets by base pairing [6] with much of this base pairing occurs within the seed region 
(nucleotides 2-8) of the miRNA (see figure) and the 3’-untranslated region (UTR) of the target 
mRNAs. In plants, this sequence complementarity is exact whereas in humans, miRNA : 
mRNA binding is imprecise [7]. The 8 nucleotides within the seed region facilitate the majority 
of miRNA mediated repression, and are also the binding sites recognised by most target-
prediction software packages [8]. The functional importance of miRNAs is emphasised by the 
fact that each miRNA is predicted to regulate the expression of thousands of protein coding 
genes, supporting the idea that miRNAs can influence almost every biological process, 
furthermore, genetic deletion of genes involved in miRNA processing can be fatal [9]. In 
addition, miRNAs are conserved across species, emphasising the translational benefit of pre-
clinical work in this area [10].   
Functions of gastrointestinal miRNAs and their impact on the gut microbiota 
Through modifying gene expression, their ubiquitous expression and an ability to modulate 
multiple cell pathways, miRNAs are powerful signalling molecules [10, 11]. Recent studies 
have confirmed that miRNAs can contribute significantly to cell-cell communication due to the 
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fact that multiple bodily fluids such as blood, plasma, urine, seminal fluid, breast milk, saliva 
and cerebrospinal fluid contain miRNAs [12]. MiRNAs are generally stable in these fluids and 
survive extended storage making them ideal candidates as biomarkers of many diseases and 
conditions. In 2007, Valadi et al, was the first to show that vesicles known as “exosomes” were 
able to transport miRNA from one cell to another and that this miRNA was functional in the 
recipient cell [13]. Exosomes are small membrane particles (30-100nm) formed from endocytic 
compartments and released by numerous cell types [14]. Recent studies have promoted a 
strong interest in exosomes and their cargo, including miRNA, as potential biomarkers of 
disease and as therapeutic entities that could be used to treat numerous human diseases [15]. 
This interest should be tempered though by the caveat that recent research has revealed that 
non-vesicular fractions may also be present in exosomes [16]. miRNAs have the capacity to 
behave in a manner similar to hormones and can influence the phenotype of recipient cells 
which may exist a great distance from their origin [17]. 
The gut provides an ideal habitat for the microbial ecosystem known as the microbiome, 
containing an abundant population of bacteria, the composition of which is of significant 
interest in many diseases and to many fields of research [18]. The molecular basis for this 
host-microbe interaction is of critical importance to understand how the host and its resident 
microbiome interact and the role of miRNAs in this interaction between host and microbiome 
is becoming clearer. In 2011, Dalmasso et al [19] examined the expression of miRNAs in the 
colon and ileum of germ-free mice colonized with the microbiota of pathogen-free mice [20]. 
They found that a number of miRNAs were influenced by colonisation in the ileum (1 
increased) and colon (3 increased, 5 decreased) of mice in addition, they noted that altered 
expression of miRNAs and genes was higher in the colon than the ileum, reflecting a possible 
influence of microbial load on expression [19, 21]. Further evidence of this bi-directional 
relationship is seen in humans with colorectal cancer with 76 miRNAs differentially expressed 
between colorectal tumours and matched adjacent normal tissue, in addition, a number of 
these miRNAs were found to correlate significantly with specific groups of bacteria or taxa in 
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the tumour microenvironment [22, 23] suggesting that miRNAs may mediate host-microbe 
interactions and that this interaction represents a key node for intervention in colorectal cancer 
patients.  
Throughout life, diet is known to significantly impact the composition of the microbiome 
and detrimental changes in diet can lead to detrimental changes in the microbiome [24]. 
Modulating dietary intake and composition has become a key targeted intervention strategy in 
regulating the microbiome and understanding how diet can influence host-microbe interactions 
is an important part of this. While we know that components of the food we eat are important 
energy sources for the microbes in our gut, less is known about specific interactions between 
dietary particles and the microbes in our gut. Important work from Zheng et al demonstrated 
that exosome-like nanoparticles (ELNs) contained in ginger and ingested in rodent diet were 
preferentially taken up by Lactobacillaceae. Furthermore, within these ELN particles are 
miRNAs which were able to target Lactobacillus rhamnosus (LGG). Specifically, mdo-
miR7267-3p targeted the ycnE gene in LGG which resulted in increased indole-3-
carboxaldehyde (I3A which increased interleukin-22 (IL-22) production and improved gut 
barrier integrity [25].  
microRNAs are also a constitutive component of murine and human faeces, derived from the 
host epithelium, they are detectable in faeces and are essential for maintaining a normal gut 
microbiota. Their importance in gut physiology is emphasised by depletion of the DICER 
enzyme in the epithelial cells of mice which display exacerbated colitis and disturbed 
microbiota [26]. Furthermore, in-silico analysis has revealed that faecal miRNAs target 
bacterial genes with functions such as the glycosylation of mucin and structure of the 
extracellular matrix [27]. Recent work from our group has found that germ-free mice had 
decreased expression of miRNAs expressed in the gut epithelium, of interest though, when 
the microbiome was depleted following antibiotic treatment, expression of these miRNAs was 
increased in some cases (miR-200a-3p and miR-141-3p) compared to let-7b-3p, and miR-
1224-5p which were decreased in antibiotic treated mice. Moreover, their expression 
6 
 
correlated with key phyla. This data adds further relevance to the fact the perturbation of the 
microbiota at specific time points in development is important to the physiological response 
mediated by non-coding RNAs [28].  
Impact of the gut microbiome on brain function and behaviour: a role for miRNAs? 
The gut and the brain signal with each other in a manner similar to hormones, with microbes 
in the gut able to communicate with the brain and the brain able to influence microbes in the 
gut. The method by which this bi-directional communication takes place still remains to be fully 
explained but endocrine, neural, metabolic and immune pathways are likely to be involved [18, 
29, 30]. One such communication pathway, the vagus nerve, represents a key neural route 
which facilitates communication between gut microbes that can influence brain mediated 
behaviours [31] with the stress reducing effects of the commensal bacteria Lactobacillus 
rhamnosus eliminated by severing the vagus nerve [32]. Similarly, the gut can communicate 
with the brain hormonally, with gut peptides released from enteroendocrine cells modulating 
appetite [33]. During the prenatal and postnatal periods, the brain and the gut microbiota 
undergo a period of organisation and assembly that has a long-term impact on the brain and 
behaviour [34]. The cooperation of many genes and gene networks are required for adequate 
neurodevelopment [35]. In fact, disruption of these gene networks have been implicated in 
many neurodevelopmental disorders and psychiatric conditions [36, 37]. Similar to gene-gene 
interactions and functional networks, the microbiota also plays a key role in neurodevelopment 
including behaviour and structural development of the brain [38, 39]. Thus, the brain-gut-
microbiome axis represents a key communication system that, when disturbed, may be 
responsible for many immune, metabolic and psychiatric disorders. Given their role in almost 
all biological processes, it is has recently been proposed that miRNAs are recruited by the gut 
microbiome to impact on the functions of the brain-gut axis.  
The role of miRNA in regulating physiological behaviour continues to be explored, for example, 
in Drosophila, a locus mutation in miR-iab4/iab8 is responsible for the capacity of Drosophila 
to correct itself when turned upside down [40]. In mice, ablation of DICER, a key enzyme in 
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miRNA processing, increases anxiety-like behaviour [41]. Furthermore, the idea that individual 
miRNAs can influence behaviour comes from data in mice showing that miR-182, possibly 
through post-transcriptional regulation of actin regulatory proteins (ARPs), can regulate 
amygdala-dependent memory formation [42]. Similarly, in rats, basal miRNA expression in the 
reward circuitry of high and low-novelty seeking rats differs depending on the brain region 
analysed and the genotype of the rats [43] emphasising the precise role that miRNAs can 
have in specific brain regions. The microbiome regulates behaviours and physiology 
influenced by miRNAs, particularly stress and anxiety [44] and can also modulate the 
transcriptional landscape in relevant brain regions. In germ-free mice for example, rodent 
social interaction was capable of inducing RNA splicing in the amygdala, thus confirming that 
a functioning microbiome is closely linked with sociability [45] and that RNA can influence 
behaviours modulated by the gut microbiome.  
To further elucidate the role of the microbiome in gut-brain physiology and indeed, miRNA 
regulated biology, many groups have manipulated the microbiome through depletion with 
antibiotics or the germ-free mouse. Intriguingly, some of the most characteristic phenotypic 
behaviours altered in the germ-free mouse are anxiety-like and social behaviours [38, 46, 47], 
a phenotype that is also commonly observed in other animal models of disrupted microbial 
colonisation [48]. Microbial depletion using chronic antibiotic exposure results in a different 
behavioural phenotype in rats, including deficits in spatial memory, decreased visceral 
sensitivity and increased depressive-like behaviours in the forced swim test [49]. This data 
suggests that there are different times during development that the brain is vulnerable to 
manipulation of the gut microbiota although it remains to be fully understood if microbial 
manipulation of miRNA expression at different times of life may also impact behaviour [49, 
50].  
The hippocampus is a brain region associated with learning and memory,  and in the rat 
changes in miRNA expression are influenced by exposure to early life stress and interestingly, 
these changes can be reversed by treatment with antidepressants [51]. Furthermore, inhibition 
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of miR-124 in the hippocampus of mice improved performance in the Morris Water Maze task 
and also a spontaneous alternation task in a closed elevated plus maze [52], demonstrating 
the important role specific miRNAs can have on specific behaviours associated with this brain 
region. Work from our group has focussed on the possibility that the microbiome is needed for 
miRNA control of gene expression in the brain. We have previously demonstrated that [53] 
the gut microbiota can control gene expression in the brain through a network of miRNAs and 
their target mRNAs [54]. Moreover, some of these changes were only present in males, 
suggesting that expression patterns of miRNAs can be affected by sex. In this study, mir-294-
5p was increased in germ-free mice and importantly, expression was decreased upon 
recolonisation, providing clear evidence that the microbiome can control expression of miRNA 
in the brain. In-silico analysis revealed that mir-294-5p targeted the pathway associated with 
kynurenine metabolism and that genes associated with this pathway (Kat1, Tdao1) were 
differentially expressed in germ-free mice [53].  
Along with the hippocampus the prefrontal cortex (PFC) and amygdala have also 
demonstrated susceptibility to modulation by the gut microbiota. Hoban et al presented data 
that suggested that miRNA expression in these key brain regions were dependent on a 
functional gut microbiota and that this was especially important during key developmental 
windows [37]. Using germ-free mice, devoid of all microbiota, they found that miRNAs in the 
PFC and amygdala, are sensitive to the presence of a microbiome, and that upon 
recolonisation, the expression of some of these miRNAs are normalised, while some are not. 
In the amygdala, miR-183-5p and miR-182-5p were decreased in germ-free mice and 
subsequently expression was restored upon recolonisation. These miRNAs have been 
implicated in the amygdala response to fear and stress [42, 55] and also, miR-183-5p is 
increased in the circulation of depressed patients undergoing antidepressant treatment [56]. 
From this study, in-silico analysis of predicted target genes of altered miRNAs in the amygdala 
and PFC revealed a potential function of these miRNAs in neuronal development, axon 
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guidance and neuronal differentiation which further highlights the role of miRNAs in regulating 
these key pathways.   
 
Future work in this area must focus on the mechanisms underpinning these observations, 
including what factors drive this selectivity.  
Germ-free mice represent one way of interrogating the function of the microbiome and how it 
influences development. Analysis using qRT-PCR showed that the expression of some 
miRNAs are also sensitive to the depletion of the microbiota, for example, a significant 
decrease in miR-206-3p and miR-219a-2-3p and an increase in miR-369-3p in the amygdala 
of rats exposed to antibiotics. Other miRNAs that were changed in germ-free mice were 
unchanged in rats treated with antibiotics, suggesting there are different mechanisms involved 
and that the microbiota in the rat may differ slightly in the miRNAs its microbiome can 
influence. What is most intriguing about this work is that, the absence of a microbiome from 
birth effects the expression of miRNA in the brain differently than in rodents who initially have 






How the microbiome influences the expression of miRNAs, their target genes and 
subsequently how miRNAs influence behaviours mediated in the brain remains to be fully 
understood. The brain-gut axis represents an attractive starting point and much of this 
evidence has come from work on vagus nerve signalling [57, 58], and short chain fatty acids 
(SCFAs) that affect the central nervous system indirectly [59]. How miRNAs can induce 
signalling pathways via either pathway of communication will offer key mechanistic insights 
into how miRNAs can influence the brain and how they are controlled by what resides in our 
guts. Once these mechanistic insights are available, the feasibility of therapeutic targeting of 
the gut microbiome in an effort to regulate brain-gut miRNAs will become clearer. In addition, 
we expect a clearer picture of the importance of miRNA-microbe interactions to emerge. 
Cross-kingdom communication between miRNA and the microbiome represents an intriguing 
relationship to explore, the interaction of pathogenic [60] and commensal [61] bacteria with 







Figure Legends  
 
Figure 1: MicroRNA Processing 
The majority of miRNA genes are transcribed by RNA polymerase II, where, in the nucleus, 
the long primary transcript or the pri-miRNA, containing a hairpin region with the mature 
miRNA sequence within, are processed by two RNASEIII enzymes, drosha and pasha. In the 
nucleus, the endonuclease DROSHER processes the pri-miRNA into a 70-nucleotide stem-
loop structure called precursor miRNA (pre-miRNA). Following transport to the cytoplasm by 
Exportin-5; another endonuclease, DICER then processes these transcripts into duplexes of 
19-24 nucleotides in length. This duplex is subsequently loaded into the RNA induced 
silencing complex (RISC) where one strand is selected as mature and the other “passenger” 










Schematic Representation of the proposed interactions between miRNAs, the gut microbiota 
and the brain. microRNAs contained within our diet can interact with the gut microbiome, and 
disease can modify the microbiome via miRNA. In addition, the microbes in our gut can alter 
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